Tuberculosis (Edinburgh, Scotland) · 2015
Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kaur Simerpreet, Rana Vibhuti, Singh Pooja, Trivedi Garima, Anand Shashi, Kaur Amanpreet, Gupta Pawan, Jain Amita, Sharma Charu
Аннотация
Twenty-nine Kanamycin resistant clinical isolates of Mycobacterium tuberculosis from Northern India were screened to evaluate genetic mutations in rrs gene, eis gene with its promoter, and whiB7 gene along with its 5'UTR. 14 strains (~48.0%) collectively exhibited mutations in rrs, eis or whiB7 target regions. While the highest frequency of mutations was found in rrs gene, eis and whiB7 loci displayed novel mutations. The novel mutations displayed by eis and whiB7 loci were found to be associated specifically with the Kanamycin resistance as none of the twenty nine Kanamycin sensitive strains harbor them. The inclusion of novel mutations of eis and whiB7 loci will be useful in improving the specificity of future diagnostics.
Предметные рубрики MeSH
5' Untranslated RegionsAcetyltransferasesAntigens, BacterialAntitubercular AgentsBacterial ProteinsDNA Mutational AnalysisDNA, BacterialDrug Resistance, Multiple, BacterialGenotypeHumansIndiaKanamycinMicrobial Sensitivity TestsMutationMycobacterium tuberculosisPhenotypePolymerase Chain ReactionPredictive Value of TestsPromoter Regions, GeneticTuberculosis, Multidrug-Resistant